Ray Liu
Impact in
-
- Cancer-related Molecular Pathways
- Drug Transport and Resistance Mechanisms
-
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- DNA Repair Mechanisms
Papers in
-
- Ubiquitin and proteasome pathways 5
- Protein Degradation and Inhibitors 2
- Oncology 4
- Cancer-related Molecular Pathways 2
- Co-authors
- Mark Manfredi (2 shared papers)Jerome T. Mettetal (1 shared paper)Jill Donelan (1 shared paper)Arijit Chakravarty (1 shared paper)Greg Hather (3 shared papers)David C. Bouck (2 shared papers)Katherine Cosmopoulos (2 shared papers)Khristofer Garcia (2 shared papers)
- Journals
- Molecular Cancer Therapeutics (2 papers)Cancer Research (2 papers)Molecular Pharmaceutics (1 paper)Journal of Immunological Methods (1 paper)Sensors and Actuators B Chemical (1 paper)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Ray Liu
17 papers receiving 393 citations
Peers
Comparison fields: 5 of 84
- Oncology 153
- Molecular Biology 226
- Pharmacology 24
- Hematology 25
- Cancer Research 32
Countries citing papers authored by Ray Liu
This map shows the geographic impact of Ray Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ray Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ray Liu more than expected).
Fields of papers citing papers by Ray Liu
This network shows the impact of papers produced by Ray Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ray Liu. The network helps show where Ray Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ray Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 100 | |
| 2 | 2012 | 85 | |
| 3 | 2014 | 45 | |
| 4 | 2009 | 44 | |
| 5 | 2011 | 42 | |
| 6 | 2012 | 16 | |
| 7 | 2022 | 15 | |
| 8 | 2010 | 12 | |
| 9 | 2019 | 10 | |
| 10 | 2015 | 10 | |
| 11 | 2015 | 8 | |
| 12 | 2015 | 7 | |
| 13 | 2006 | 4 | |
| 14 | 2002 | 3 | |
| 15 | 2012 | 3 | |
| 16 | 2017 | 2 | |
| 17 | 2018 | 1 | |
| 18 | 2011 | 0 |
About Ray Liu
Ray Liu is a scholar working on Molecular Biology, Oncology, Biomedical Engineering, Cardiology and Cardiovascular Medicine and Computational Theory and Mathematics, having authored 18 papers that have together received 407 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Advanced Chemical Sensor Technologies (2 papers), Protein Degradation and Inhibitors (2 papers), Computational Drug Discovery Methods (2 papers), Heart Failure Treatment and Management (2 papers), Microtubule and mitosis dynamics (2 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Oncology (153 citations), Molecular Biology (226 citations), Pharmacology (24 citations), Hematology (25 citations) and Cancer Research (32 citations). Ray Liu has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Mark Manfredi, Jerome T. Mettetal, Jill Donelan, Arijit Chakravarty, Greg Hather, David C. Bouck, Katherine Cosmopoulos, Khristofer Garcia, Jonathan L. Blank and Eric S. Lightcap. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, Molecular Pharmaceutics, Journal of Immunological Methods and Sensors and Actuators B Chemical.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.